Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) has been given a consensus recommendation of "Buy" by the seven brokerages that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating, one has given a buy rating and three have assigned a strong buy rating to the company.
RBGLY has been the topic of a number of research reports. HSBC upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. Barclays downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a report on Tuesday, February 4th. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Wednesday, December 11th. Finally, Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a "strong-buy" rating to a "hold" rating in a report on Monday, November 4th.
View Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group stock opened at $13.46 on Thursday. The company's 50-day moving average price is $12.50 and its 200-day moving average price is $12.18. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $15.03. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69.
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.